BDBM100289 US8501744, 5
SMILES: CC(C)C[C@H](NC(=O)c1ccc(cc1)N1CCN(C)CC1)C(=O)N1C[C@H](C)[C@H]2OCC(=O)[C@@H]12
InChI Key: InChIKey=BCYUATIIMJMQLA-CZEIZJIKSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cathepsin K (Homo sapiens (Human)) | BDBM100289 (US8501744, 5) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 0.75 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amura Therapeutics, Limited US Patent | Assay Description In vitro cathepsin inhibition assay. | US Patent US8501744 (2013) BindingDB Entry DOI: 10.7270/Q2D7992S | |||||||||||
More data for this Ligand-Target Pair |